Perceptronix - Early Diagnosis, Better Outcomes
   
   

OralAdvance™ at Ontario Dental Association Annual Spring Meeting

Vancouver, BC, April 29, 09 – Perceptronix Medical Inc. Laboratories (PMI Labs) will be exhibiting at the Ontario Dental Association Annual Spring Meeting on April 30 - May 1, 2009 at the Metro Toronto Convention Centre. PMI Labs will be showcasing OralAdvance™, an informative new test for assessing the malignant potential of oral lesions at booth 544.

With recent advances in visualization techniques for the oral cavity, dentists are encountering more suspicious lesions. OralAdvanceT, with its soft cyto-brush sample collection kit, provides dentists with an informative new option for assessing these lesions when biopsy is not warranted or possible. It provides an objective measure of gross DNA abnormality that can give additional information about the pre-malignant or malignant nature of a lesion.

About PMI Labs
Perceptronix Medical Inc. Laboratories (PMI Labs, Vancouver, Canada) are cancer diagnostics laboratories specializing in provision of innovative tests for the early detection of cancer based on quantitative cytology, including tests for oral cancer (www.OralAdvance.com) and lung cancer (www.LungSign.com). The Company's technology was developed in partnership with the British Columbia Cancer Agency (Vancouver, Canada).

Quantitative cytology provides physicians with a distinctive cytopathology assessment based on an objective, computer-based measurement of large-scale DNA abnormality that can indicate precancerous or cancerous changes.

For further information contact:

Alexei Doudkine, PhD
Director of Business Development
Perceptronix Medical Inc.
555 West 8th Avenue, Vancouver, BC, V5Z 1C6
Phone: 604-629-8785
Email: adoudkine@perceptronix.com  
 


 

 

 

 

News and Events